Miller Anestesia

206. Mushlin PS,Gelman S: Liver dysfunction after anes-

thesia.

Benumof JL, Saidman LJ (eds): Anesthesia

& Perioperative Complications, 2nd ed. St Louis,

CV Mosby, 1999, p 441.

207. Bardag-Gorce F, French BA, Li J, et al: The impor-

tance of cycling of blood alcohol levels in the patho-

genesis of experimental alcoholic liver disease in

rats. Gastroenterology 123:325, 2002.

208. Tonnesen H, Kehlet H: Preoperative alcoholism and

postoperative morbidity. Br J Surg 86:869, 1999.

209. Nanji AA, Su GL, Laposata M, et al: Pathogenesis of

alcoholic liver disease—recent advances. Alcohol

Clin Exp Res 26:731, 2002.

210. Lieber CS: Alcoholic liver injury: Pathogenesis and

therapy in 2001. Pathol Biol 49:738, 2001.

211. Lieber CS: Microsomal ethanol-oxidizing system

(MEOS): The first 30 years (1968-1998)—a review.

Alcohol Clin Exp Res 23:991, 1999.

212. Lieber CS: Cytochrome P-4502E1: Its physiological

and pathological role. Physiol Rev 77:517, 1997.

213. Zima T, Fialova L, Mestek O, et al: Oxidative stress,

metabolism of ethanol and alcohol-related diseases.

J Biomed Sci 8:59, 2001.

214. Bosron WF, Li TK: Genetic polymorphism of

human liver alcohol and aldehyde dehydrogenases,

and their relationship to alcohol metabolism and

alcoholism. Hepatology 6:502, 1986.

215. Ehrig T, Bosron WF, Li TK: Alcohol and aldehyde

dehydrogenase. Alcohol Alcohol 25:105, 1990.

216. Ramchandani VA, Bosron WF, Li TK: Research

advances in ethanol metabolism. Pathol Biol 49:676,

2001.

217. Sherman DI,Ward RJ,Warren-Perry M, et al: Asso-

ciation of restriction fragment length polymor-

phism in alcohol dehydrogenase 2 gene with alcohol

induced liver damage. BMJ 307:1388, 1993.

218. Panes J, Soler X, Pares A, et al: Influence of liver

disease on hepatic alcohol and aldehyde dehydro-

genases. Gastroenterology 97:708, 1989.

219. Poupon RE, Nalpas B, Coutelle C, et al: Polymor-

phism of alcohol dehydrogenase, alcohol and alde-

hyde dehydrogenase activities: Implication in

alcoholic cirrhosis in white patients. The French

Group for Research on Alcohol and Liver. Hepato-

logy 15:1017, 1992.

220. Crabb DW, Edenberg HJ, BosronWF, et al: Genoty-

pes for aldehyde dehydrogenase deficiency and

alcohol sensitivity. The inactive ALDH2(2) allele is

dominant. J Clin Invest 83:314, 1989.

221. Thiele GM, Miller JA, Klassen LW, et al: Long-term

ethanol administration alters the degradation of

acetaldehyde adducts by liver endothelial cells.

Hepatology 24:643, 1996.

222. Shaw S, Rubin KP, Lieber CS: Depressed hepatic

glutathione and increased diene conjugates in alco-

holic liver disease. Evidence of lipid peroxidation.

Dig Dis Sci 28:585, 1983.

223. Williams AJ, Barry RE: Superoxide anion produc-

tion and degranulation of rat neutrophils in res-

ponse to acetaldehyde-altered liver cell membranes.

Clin Sci 71:313, 1986.

224. Holt K, Bennett M, Chojkier M: Acetaldehyde sti-

mulates collagen and noncollagen protein produc-

tion by human fibroblasts. Hepatology 4:843, 1984.

225. Roll FJ, Bissell DM, Perez HD: Human hepatocytes

metabolizing ethanol generate a non-polar chemo-

tactic factor for human neutrophils. Biochem

Biophys Res Commun 137:688, 1986.

226. Granger DN, Korthuis RJ: Physiologic mechanisms

of postischemic tissue injury. Annu Rev Physiol

57:311, 1995.

227. Carden DL, Young JA, Granger DN: Pulmonary

microvascular injury after intestinal ischemia-reperfu-

sion: Role of P-selectin. J Appl Physiol 75:2529, 1993.

228. Mulligan MS, Smith CW, Anderson DC, et al: Role

of leukocyte adhesion molecules in complement-

induced lung injury. J Immunol 150:2401, 1993.

229. McClain C, Hill D, Schmidt J, et al: Cytokines and

alcoholic liver disease. Semin Liver Dis 13:170, 1993.

230. Mezey E: Commentary on the hypermetabolic state

and the role of oxygen in alcohol-induced liver

injury. Recent Dev Alcohol 2:135, 1984.

231. Ito D, Ishii H, Kato S, et al: Significance of alcohol

dehydrogenase (ADH) as a marker of hepatic cen-

trilobular injury: A biochemical and immunohisto-

chemical study. Alcohol Alcohol Suppl 1:523, 1987.

232. Nanji AA, Zakim D: Alcoholic liver disease.

Zakim D, Boyer T (eds): Hepatology: A Textbook of

Liver Disease, 3rd ed. Philadelphia, WB Saunders,

1996, p 891.

233. Oshita M, Takei Y, Kawano S, et al: Endogenous

nitric oxide attenuates ethanol-induced perturba-

tion of hepatic circulation in the isolated perfused

rat liver. Hepatology 20:961, 1994.

234. Nanji AA, Greenberg SS, Tahan SR, et al: Nitric

oxide production in experimental alcoholic liver

disease in the rat: Role in protection from injury.

Gastroenterology 109:899, 1995.

235. Nordmann R: Alcohol and antioxidant systems.

Alcohol Alcohol 29:513, 1994.

236. Reinke LA,KotakeY,McCay PB,et al: Spin-trapping

studies of hepatic free radicals formed following the

acute administration of ethanol to rats:

vivo

detection of 1-hydroxyethyl radicals with PBN. Free

Radic Biol Med 11:31, 1991.

237. Nanji AA, Griniuviene B, Sadrzadeh SM, et al: Effect

of type of dietary fat and ethanol on antioxidant

enzyme mRNA induction in rat liver. J Lipid Res

36:736, 1995.

238. Rosser BG, Gores GJ: Liver cell necrosis: Cellular

mechanisms and clinical implications. Gastroente-

rology 108:252, 1995.

239. Wang JF, Greenberg SS, Spitzer JJ: Chronic alcohol

administration stimulates nitric oxide formation in

the rat liver with or without pretreatment by lipo-

polysaccharide. Alcohol Clin Exp Res 19:387, 1995.

240. Skinner KA,White CR, Patel R, et al: Nitrosation of

uric acid by peroxynitrite.Formation of a vasoactive

nitric oxide donor. J Biol Chem 273:24491, 1998.

241. Beckman JS: Protein tyrosine nitration and peroxy-

nitrite. FASEB J 16:1144, 2002.

242. Beckman JS: -OONO: Rebounding from nitric

oxide. Circ Res 89:295, 2001.

243. Reiter CD, Teng RJ, Beckman JS: Superoxide reacts

with nitric oxide to nitrate tyrosine at physiological

pH via peroxynitrite. J Biol Chem 275:32460, 2000.

244. Beckman JS, Beckman TW, Chen J, et al: Apparent

hydroxyl radical production by peroxynitrite:

Implications for endothelial injury from nitric

oxide and superoxide. Proc Natl Acad Sci U S A

87:1620, 1990.

245. Lauterburg BH, Davies S, Mitchell JR: Ethanol

suppresses hepatic glutathione synthesis in rats in

vivo. J Pharmacol Exp Ther 230:7, 1984.

246. Quinn PG, Johnston DE: Detection of chronic liver

disease: Costs and benefits. Gastroenterologist 5:58,

1997.

247. McCaughan GW, Gorrell MD, Bishop GA, et al:

Molecular pathogenesis of liver disease: An appro-

ach to hepatic inflammation, cirrhosis and liver

transplant tolerance. Immunol Rev 174:172, 2000.

248. Chung RT, Jaffe DL, Friedman LS: Complications of

chronic liver disease. Crit Care Clin 11:431, 1995.

249. Rakela J, Krowka MJ: Cardiovascular and pulmo-

nary complications of liver disease.

Zakim D,

Boyer T (eds): Hepatology: A Textbook of Liver

Disease, 3rd ed. Philadelphia, WB Saunders, 1996,

p 675.

250. Daoud FS, Reeves JT, Schaefer JW: Failure of

hypoxic pulmonary vasoconstriction in patients

with liver cirrhosis. J Clin Invest 51:1076, 1972.

251. Lazaridis KN, Frank JW, Krowka MJ, et al: Hepatic

hydrothorax: Pathogenesis, diagnosis, and manage-

ment. Am J Med 107:262, 1999.

252. Jalan R, Hayes PC: Hepatic encephalopathy and

ascites. Lancet 350:1309, 1997.

253. Arroyo V, Gines P: Mechanism of sodium retention

and ascites formation in cirrhosis. J Hepatol 17:S24,

1993.

254. Moreau R: Hepatorenal syndrome in patients with

cirrhosis. J Gastroenterol Hepatol 17:739, 2002.

255. Moore KP, Wong F, Gines P, et al: The management

of ascites in cirrhosis: Report on the consensus con-

ference of the International Ascites Club. Hepato-

logy 38:258, 2003.

256. Moreau R, Lebrec D: Acute renal failure in patients

with cirrhosis: Perspectives in the age of MELD.

Hepatology 37:233, 2003.

257. Lotterer E,Wengert A,FleigWE: Transjugular intra-

hepatic portosystemic shunt: Short-term and long-

term effects on hepatic and systemic hemodynamics

in patients with cirrhosis. Hepatology 29:632,

1999.

258. Wolff B, Machill K, Schumacher D, et al: MARS

dialysis in decompensated alcoholic liver disease: A

single-center experience. Liver Transpl 13:1189,

2007.

259. de Franchis R, Primignani M: Natural history of

portal hypertension in patients with cirrhosis. Clin

Liver Dis 5:645, 2001.

260. Vaughan RB, Chin-Dusting JP: Current pharmaco-

therapy in the management of cirrhosis: Focus on

the hyperdynamic circulation. Expert Opin Phar-

macother 4:625, 2003.

261. Silva G, Navasa M, Bosch J, et al: Hemodynamic

effects of glucagon in portal hypertension. Hepato-

logy 11:668, 1990.

262. Cerini R, Koshy A, Hadengue A, et al: Effects of

glucagon on systemic and splanchnic circulation in

conscious rats with biliary cirrhosis. J Hepatol 9:69,

1989.

263. Moller S, Bendtsen F, Henriksen JH: Vasoactive

substances in the circulatory dysfunction of cirrho-

sis. Scand J Clin Lab Invest 61:421, 2001.

264. Moller S, Bendtsen F, Henriksen JH: Splanchnic and

systemic hemodynamic derangement in decom-

pensated cirrhosis. Can J Gastroenterol 15:94,

2001.

265. Cahill PA, Redmond EM, Sitzmann JV: Endothelial

dysfunction in cirrhosis and portal hypertension.

Pharmacol Ther 89:273, 2001.

266. Bomzon A, Blendis LM: Vascular reactivity in expe-

rimental portal hypertension. Am J Physiol

252:G158, 1987.

267. Martin PY, Gines P, Schrier RW: Nitric oxide as a

mediator of hemodynamic abnormalities and

sodium and water retention in cirrhosis. N Engl J

Med 339:533, 1998.

268. Martin PY, Ohara M, Gines P, et al: Nitric oxide

synthase (NOS) inhibition for one week improves

renal sodium and water excretion in cirrhotic rats

with ascites [published erratum appears in J Clin

Invest 1998 Aug 1;102(3):inside back cover]. J Clin

Invest 101:235, 1998.

269. Niederberger M, Martin PY, Gines P, et al: Norma-

lization of nitric oxide production corrects arterial

vasodilation and hyperdynamic circulation in cirr-

hotic rats. Gastroenterology 109:1624, 1995.

270. Matsumoto A, Ogura K, Hirata Y, et al: Increased

nitric oxide in the exhaled air of patients with

decompensated liver cirrhosis. Ann Intern Med

123:110, 1995.

Fisiología y fisiopatología hepáticas

205

Sección I

Fisiología y anestesia